1. Zhang, Xiaoyan, Yang, Weili, Wang, Junpei, Guan, Youfei, Yang, Jichun. 2017. FAM3 gene family: A promising therapeutical target for NAFLD and type 2 diabetes. In Metabolism: clinical and experimental, 81, 71-82. doi:10.1016/j.metabol.2017.12.001. https://pubmed.ncbi.nlm.nih.gov/29221790/
2. Ma, Tianfang, Jin, Lianjin, Bai, Shanshan, Dong, Xuesen, Dong, Yan. . Loss of feedback regulation between FAM3B and androgen receptor driving prostate cancer progression. In Journal of the National Cancer Institute, 116, 421-433. doi:10.1093/jnci/djad215. https://pubmed.ncbi.nlm.nih.gov/37847647/
3. Zhao, Huaxiang, He, Qing, Wu, Xiantao, Zhu, Xuechen, Ding, Yi. 2023. Identification of rare loss-of-function variants in FAM3B associated with non-syndromic orofacial clefts. In Genomics, 115, 110630. doi:10.1016/j.ygeno.2023.110630. https://pubmed.ncbi.nlm.nih.gov/37105387/
4. Wang, Wenfang, Wang, Meijuan, Ahmed, Madiha Mohammed Saleh, Musa, Mazen, Chen, Xi. 2022. FAM3B Serves as a Biomarker for the Development and Malignancy of Oral Lichen Planus. In International journal of general medicine, 15, 763-776. doi:10.2147/IJGM.S346617. https://pubmed.ncbi.nlm.nih.gov/35082524/
5. Zhang, Wenxiang, Chen, Siyu, Zhang, Zhao, Wang, Chen, Liu, Chang. 2017. FAM3B mediates high glucose-induced vascular smooth muscle cell proliferation and migration via inhibition of miR-322-5p. In Scientific reports, 7, 2298. doi:10.1038/s41598-017-02683-3. https://pubmed.ncbi.nlm.nih.gov/28536423/
6. Maciel-Silva, Paula, Caldeira, Izabela, de Assis Santos, Icaro, Belizário, José Ernesto, Garay-Malpartida, Humberto Miguel. 2018. FAM3B/PANDER inhibits cell death and increases prostate tumor growth by modulating the expression of Bcl-2 and Bcl-XL cell survival genes. In BMC cancer, 18, 90. doi:10.1186/s12885-017-3950-9. https://pubmed.ncbi.nlm.nih.gov/29357840/
智鼠故事 
